Manuel Recio

Ceftazidime-avibactam in the treatment of infections caused by KPC-producing Klebsiella pneumoniae: factors associated with clinical efficacy in a single-center cohort

Juan José Castón, Marina Gallo, M. Arance García et al. · International Journal of Antimicrobial Agents · 2020 · 42 citations

Life Sciences, Infectious Diseases, Microbiology +11

Efficacy and safety of a structured de-escalation from antipseudomonal β-lactams in bloodstream infections due to Enterobacterales (SIMPLIFY): an open-label, multicentre, randomised trial

Luis Eduardo López-Cortés, Mercedes Delgado-Valverde, Elisa Moreno-Mellado et al. · The Lancet Infectious Diseases · 2024 · 32 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +16

Impact of an Antimicrobial Stewardship Program on the Incidence of Carbapenem Resistant Gram-Negative Bacilli: An Interrupted Time-Series Analysis

Teresa López-Viñau, Germán Peñalva, Lucrecia García-Martinez et al. · Antibiotics · 2021 · 23 citations · Full text

Life Sciences, Infectious Diseases, Microbiology +17

Randomised, double-blind, placebo-controlled, phase 2, superiority trial to demonstrate the effectiveness of faecal microbiota transplantation for selective intestinal decolonisation of patients colonised by carbapenemase-producing <i>Klebsiella pneumoniae</i> (KAPEDIS)

Elena Pérez‐Nadales, Ángela Cano, Manuel Recio et al. · BMJ Open · 2022 · 11 citations · Full text

Life Sciences, Infectious Diseases, Microbiology +13